Exclusive

Publication

Byline

Singapore Clinical Trial: A First-in-Human, Open-Label, Multi-Center Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ALK201 for Injection in Adult Participants with Advanced Solid Tumors

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A First-in-Human, Open-Label, Multi-Center Phase I/II Clinical Study to Evaluate the Safety, Toler... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine (MK-5884) Versus Placebo for the Prevention of COPD Exacerbations in Adults with a History of Moderate or Severe Exacerbations While Receiving Standard of Care (ENHANCE-3)

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety ... Read More


Clinical Trial: Virtual Reality and Point-of-View Video Modeling for Dental Anxiety in Children

U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07894744) titled 'Virtual Reality and Point-of-View Video Modeling for Dental Anxiety in Children' on Oct. 19... Read More


Singapore Clinical Trial: An open-label, roll-over study evaluating the long-term safety and efficacy of an oral dose of verducatib q.d. in patients with bronchiectasis (AIRTIVITY®-ON)

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'An open-label, roll-over study evaluating the long-term safety and efficacy of an oral dose of ver... Read More


Singapore Clinical Trial: A Phase 3, Multicenter, Open-Label, Randomized Study to Evaluate Inobrodib in Combination with Pomalidomide and Dexamethasone Versus Standard Available Therapy in Patients with Relapsed or Refractory Multiple Myeloma

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Open-Label, Randomized Study to Evaluate Inobrodib in Combination with Pom... Read More


Clinical Trial: Short-Term Efficacy and Safety of Combined Deep Sclerectomy With Trabeculotomy in Advanced Glaucoma: A Prospective Interventional Study

U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07895537) titled 'Short-Term Efficacy and Safety of Combined Deep Sclerectomy With Trabeculotomy in Advanced ... Read More


Singapore Clinical Trial: A Long-Term Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder for Treatment of Pulmonary Arterial Hypertension

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Long-Term Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder for Treatment of... Read More


Clinical Trial: Clinical Hypnosis Versus Guided Imagery for Dissociative Symptoms in Adults

U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07895875) titled 'Clinical Hypnosis Versus Guided Imagery for Dissociative Symptoms in Adults' on Oct. 19. B... Read More


Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4174794 in Participants with Obesity or Overweight who are Otherwise Healthy

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose-Escalation Study to ... Read More


Singapore Clinical Trial: A Phase 1, Open-Label, Pharmacokinetic Study of Lepodisiran Administered as a Single Subcutaneous Dose in the Abdomen, Thigh, or Upper Arm in Healthy Participants with High Lipoprotein(a)

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Open-Label, Pharmacokinetic Study of Lepodisiran Administered as a Single Subcutaneous ... Read More